1. Home
  2. AVLN vs BV Comparison

AVLN vs BV Comparison

Compare AVLN & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$38.37

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

HOLD

Current Price

$11.30

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVLN
BV
Founded
N/A
1939
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2026
2018

Fundamental Metrics

Financial Performance
Metric
AVLN
BV
Price
$38.37
$11.30
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$14.50
AVG Volume (30 Days)
163.8K
1.2M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.61
Revenue Next Year
N/A
$1.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.90
$10.42
52 Week High
$40.17
$15.00

Technical Indicators

Market Signals
Indicator
AVLN
BV
Relative Strength Index (RSI) 67.65 37.39
Support Level $26.38 $10.42
Resistance Level $40.08 $12.68
Average True Range (ATR) 2.60 0.42
MACD 0.54 -0.02
Stochastic Oscillator 94.55 28.82

Price Performance

Historical Comparison
AVLN
BV

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: